Off-label use of becaplermin gel (recombinant platelet-derived growth factor-BB) for treatment of mucosal defects after corticocancellous bone graft: report of 2 cases with review of the literature. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons [J Oral Maxillofac Surg] Journal article

Title	Off-label use of becaplermin gel (recombinant platelet-derived growth factor-BB) for treatment of mucosal defects after corticocancellous bone graft: report of 2 cases with review of the literature.
Author(s)	Calhoun CC, Cardenes O, Ducksworth J, Le AD
Institution	Division of Oral and Maxillofacial Surgery, Harbor/University of California, Medical Center, Torrance, CA 90509, USA. cccal69@aol.com
Source	J Oral Maxillofac Surg 2009 Nov; 67(11):2516-20.
MeSH	Adolescent Alveolar Ridge Augmentation Angiogenesis Inducing Agents Bone Transplantation Drug Labeling Graft Survival Humans Male Mandible Oral Surgical Procedures, Preprosthetic Platelet-Derived Growth Factor Recombinant Proteins Surgical Flaps Surgical Wound Dehiscence Treatment Outcome Wound Healing Young Adult
Language	eng
Pub Type(s)	Case Reports Journal Article Review
PubMed ID	19837327

Advertise on this site.